Primary care NPs and PAs play a vital role in early recognition of age-related macular degeneration (AMD) and referral to ophthalmologists. In this 1-hour on-demand webcast, national experts in AMD management discuss clinical manifestations of the disease, lifestyle and dietary changes that may help reduce patients’ risk of progression to advanced disease, and the risks and benefits of available treatment options.
Interactive video lecture
After completing this activity, participants should be better able to:
- Recognize early, mid-, and late clinical signs of AMD in order to prompt early referral of patients for treatment
- Describe the risks and benefits of treatment options for AMD to patients and their families/caregivers
- Identify lifestyle and dietary modifications that patients can make to reduce the risk of AMD progression and improve their quality of life
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit.
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until June 2, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Daniel Forsberg, PA-C, MPH, CPH, DFAAPA, Touro College, Skokie, Illinois
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Knudtson has no relevant financial relationships to disclose.
Dr Kuriyan: consulting: Alimera Sciences, Allergan, Bausch & Lomb, Novartis, Optos, Recens Medical, Regeneron, Spark Therapeutics; contracted research: Second Sight; consulting/contracted research: Genentech/Roche.
Dr Spaide: consulting: Genentech, Heidelberg Engineering, Regeneron, Roche; consulting/royalties: Topcorn Medical; royalties: Dutch Ophthalmic Research Center.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: June 3, 2021
Expiration date: June 2, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 101721RG-2